Company / Inventory
Ginkgo Bioworks Holdings, Inc. Inventory History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$46.0K
FY2023
5-year range
$46.0K / $4.4M
FY2020-FY2023
Trend
-98.9%
vs FY2022
Sector context
#108 of 108
Health Care
What the data says
Among 108 Health Care companies, Ginkgo Bioworks Holdings, Inc. is in the bottom 0% for inventory. Declined from $3M to $46,000 over the past 2 years.
Based on SEC 10-K filings.
$46,000 in FY2023 with a 3-year CAGR of -74.4%.
Declined from $3M to $46,000 over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -74.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 108This company $46.0K Sector average $862.4M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -74.4%, indicating a declining trend.
- In FY2023, inventory decreased 98.9% year-over-year.
- Ranks #108 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $46.0K | -98.9% |
| FY2022 | $4.4M | +29.8% |
| FY2021 | $3.4M | +22.9% |
| FY2020 | $2.7M | - |
| FY2019 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026